Gasdermin E suppresses tumour growth by activating anti-tumour immunity Z Zhang, Y Zhang, S Xia, Q Kong, S Li, X Liu, C Junqueira, KF Meza-Sosa, ... Nature 579 (7799), 415-420, 2020 | 1271 | 2020 |
Super-enhancer-driven transcriptional dependencies in cancer S Sengupta, RE George Trends in cancer 3 (4), 269-281, 2017 | 286 | 2017 |
BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells DN Debruyne, R Dries, S Sengupta, D Seruggia, Y Gao, B Sharma, ... Nature 572 (7771), 676-680, 2019 | 111 | 2019 |
Brg1 is required for Cdx2-mediated repression of Oct4 expression in mouse blastocysts K Wang, S Sengupta, L Magnani, CA Wilson, RW Henry, JG Knott PloS one 5 (5), e10622, 2010 | 79 | 2010 |
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes S Sengupta, S Das, AC Crespo, AM Cornel, AG Patel, NR Mahadevan, ... Nature cancer 3 (10), 1228-1246, 2022 | 58* | 2022 |
Chemotherapy-induced late transgenerational effects in mice LL Kujjo, EA Chang, RJG Pereira, S Dhar, B Marrero-Rosado, ... PloS one 6 (3), e17877, 2011 | 58 | 2011 |
Regulation of the retinoblastoma–E2F pathway by the ubiquitin–proteasome system S Sengupta, RW Henry Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1849 (10 …, 2015 | 51 | 2015 |
Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family TJ Liban, EM Medina, S Tripathi, S Sengupta, RW Henry, NE Buchler, ... Proceedings of the National Academy of Sciences 114 (19), 4942-4947, 2017 | 44 | 2017 |
Formation of human neuroblastoma in mouse-human neural crest chimeras MA Cohen, S Zhang, S Sengupta, H Ma, GW Bell, B Horton, B Sharma, ... Cell Stem Cell 26 (4), 579-592. e6, 2020 | 43 | 2020 |
Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch AM Cornel, E Dunnebach, DA Hofman, S Das, S Sengupta, ... Journal for Immunotherapy of Cancer 10 (12), 2022 | 26 | 2022 |
Effect of human chorionic gonadotropin (hCG) on expression of vascular endothelial growth factor a (VEGF-a) in human mid-secretory endometrial cells in three-dimensional … S Sengupta, J Sengupta, S Mittal, S Kumar, D Ghoshi Indian J Physiol Pharmacol 52 (1), 19-30, 2008 | 16 | 2008 |
The evolutionarily conserved C-terminal domains in the mammalian retinoblastoma tumor suppressor family serve as dual regulators of protein stability and transcriptional potency S Sengupta, R Lingnurkar, TS Carey, M Pomaville, P Kar, M Feig, ... Journal of Biological Chemistry 290 (23), 14462-14475, 2015 | 13 | 2015 |
Extracellular domain shedding of the ALK receptor mediates neuroblastoma cell migration H Huang, A Gont, L Kee, R Dries, K Pfeifer, B Sharma, DN Debruyne, ... Cell reports 36 (2), 2021 | 12 | 2021 |
CKLF instigates a “cold” microenvironment to promote MYCN-mediated tumor aggressiveness X Qin, A Lam, X Zhang, S Sengupta, JB Iorgulescu, H Ni, S Das, M Rager, ... Science Advances 10 (11), eadh9547, 2024 | 1 | 2024 |
Abstract C002: CKLF attracts CCR4-expressing CD4+ cells to foster immune repression and tumor aggressiveness in MYCN-driven neuroblastoma X Qin, H Feng, A Lam, X Zhang, S Sengupta, B Iorgulescu, S Das, Z Zhou, ... Cancer Research 84 (22_Supplement), C002-C002, 2024 | | 2024 |
Novel miRNA-inducing drugs enable differentiation of retinoic acid-resistant neuroblastoma cells LD Nguyen, S Sengupta, K Cho, A Floru, RE George, AM Krichevsky bioRxiv, 2024.06. 05.597584, 2024 | | 2024 |
Erratum to: Defining neuroblastoma: from origin to precision medicine S Sengupta, S Das, AC Crespo | | 2024 |
Abstract LB_C20: A tumor-associated chemokine attracts CCR4-expressing CD4+ cells to foster immune repression and tumor aggressiveness in MYCN-driven … X Qin, A Lam, X Zhang, S Sengupta, JB Iorgulescu, S Das, Z Zhou, T Zuo, ... Molecular Cancer Therapeutics 22 (12_Supplement), LB_C20-LB_C20, 2023 | | 2023 |
Abstract A08: Divergent tumor cell states in neuroblastoma possess distinct immunogenic phenotypes S Sengupta, S Das, AC Crespo, AM Cornel, AG Patel, NR Mahadevan, ... Cancer Immunology Research 10 (12_Supplement), A08-A08, 2022 | | 2022 |
Abstract B58: Gasdermin E suppresses tumor growth by activating antitumor immunity Z Zhang, Y Zhang, S Xia, Q Kong, S Li, X Liu, C Junqueira, J Ansara, ... Cancer Immunology Research 8 (3_Supplement), B58-B58, 2020 | | 2020 |